Cargando…

Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases

Over the last decades, antiplatelet agents, mainly aspirin and P2Y(12) receptor antagonists, have significantly reduced morbidity and mortality associated with arterial thrombosis. Their pharmacological characteristics, including pharmacokinetic/pharmacodynamics profiles, have been extensively studi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jourdi, Georges, Lordkipanidzé, Marie, Philippe, Aurélien, Bachelot-Loza, Christilla, Gaussem, Pascale
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658271/ https://www.ncbi.nlm.nih.gov/pubmed/34884884 http://dx.doi.org/10.3390/ijms222313079

Ejemplares similares

Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches
por: Jourdi, Georges, et al.
Publicado: (2022)

Antiplatelet Therapy in Atherothrombotic Diseases: Similarities and Differences Across Guidelines
por: Jourdi, Georges, et al.
Publicado: (2022)

Bothrops atrox and Bothrops lanceolatus Venoms In Vitro Investigation: Composition, Procoagulant Effects, Co-Factor Dependency, and Correction Using Antivenoms
por: Larréché, Sébastien, et al.
Publicado: (2023)

P2Y(12) Inhibition beyond Thrombosis: Effects on Inflammation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Platelet‐mapping assay for monitoring antiplatelet therapy during mechanical circulatory support in children: A retrospective observational study
por: Giorni, Chiara, et al.
Publicado: (2017)

Platelet Functions During Extracorporeal Membrane Oxygenation. Platelet–Leukocyte Aggregates Analyzed by Flow Cytometry as a Promising Tool to Monitor Platelet Activation
por: Mansour, Alexandre, et al.
Publicado: (2020)

Impact of age on in vitro metabolism of clopidogrel: a potential explanation for high on-treatment platelet reactivity in the elderly?
por: Pontis, Adeline, et al.
Publicado: (2022)

No influence of the VAMP8 rs1010 single nucleotide polymorphism on platelet functions in vitro
por: Gaussem, Pascale, et al.
Publicado: (2009)

Another “String to the Bow” of PJ34, a Potent Poly(ADP-Ribose)Polymerase Inhibitor: An Antiplatelet Effect through P2Y(12) Antagonism?
por: Lechaftois, Marie, et al.
Publicado: (2014)

Impact of Aspirin and Clopidogrel Interruption on Platelet Function in Patients Undergoing Major Vascular Surgery
por: Le Manach, Yannick, et al.
Publicado: (2014)

Comparative In Vitro Study of Various α(2)-Adrenoreceptor Agonist Drugs for Ticagrelor Reversal
por: Porta Bonete, Guillaume, et al.
Publicado: (2020)

Soluble p75 neurotrophic receptor as a reliable biomarker in neurodegenerative diseases: what is the evidence?
por: Jourdi, Georges, et al.
Publicado: (2023)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
por: Carré, Julie, et al.
Publicado: (2021)

Novel aspects of antiplatelet therapy in cardiovascular disease
por: Gremmel, Thomas, et al.
Publicado: (2018)

Antiplatelet therapy in cardiovascular disease: Current status and future directions
por: Passacquale, Gabriella, et al.
Publicado: (2022)

Human endoglin as a potential new partner involved in platelet–endothelium interactions
por: Rossi, Elisa, et al.
Publicado: (2017)

Endoglin Is an Endothelial Housekeeper against Inflammation: Insight in ECFC-Related Permeability through LIMK/Cofilin Pathway
por: Rossi, Elisa, et al.
Publicado: (2021)

Implications of the Antiplatelet Therapy Gap Left With Discontinuation of Prasugrel in Canada
por: Lordkipanidzé, Marie, et al.
Publicado: (2020)

Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation()
por: Philippe, Aurélien, et al.
Publicado: (2023)

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month
por: Eyraud, Daniel, et al.
Publicado: (2018)

No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19
por: Petrazzuolo, Adriana, et al.
Publicado: (2020)

Balancing Antiplatelet and Anticoagulant Therapies in Patients with Cardiovascular Disease
por: Carreras, Edward T., et al.
Publicado: (2013)

Novel Antiplatelet Therapies for Atherothrombotic Diseases
por: Majithia, Arjun, et al.
Publicado: (2019)

Oral antiplatelet therapy for atherothrombotic disease: overview of current and emerging treatment options
por: Fintel, Dan J
Publicado: (2012)

Personalized Approaches to Antiplatelet Treatment for Cardiovascular Diseases: An Umbrella Review
por: Oliva, Angelo, et al.
Publicado: (2023)

Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents
por: Testa, L., et al.
Publicado: (2010)

Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
por: Hong, Bum-Kee
Publicado: (2010)

Peripheral interventions and antiplatelet therapy: Role in current practice
por: Singh, Pahul, et al.
Publicado: (2017)

Antiplatelet treatment in the primary prophylaxis of cardiovascular disease in patients with arterial hypertension
por: Osińska, Angelika, et al.
Publicado: (2017)

Antiplatelet Therapy in Diabetes: Efficacy and Limitations of Current Treatment Strategies and Future Directions
por: Angiolillo, Dominick J.
Publicado: (2009)

Novel antiplatelet agents in the prevention of cardiovascular complications – focus on ticagrelor
por: Marczewski, Margaret M, et al.
Publicado: (2010)

Diabetes Mellitus and Cardiovascular Prevention: The Role and the Limitations of Currently Available Antiplatelet Drugs
por: Tufano, A., et al.
Publicado: (2011)

Immature platelet fraction in cardiovascular diagnostics and antiplatelet therapy monitoring
por: Gumiężna, Karolina, et al.
Publicado: (2023)

Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy
por: Patail, Haris, et al.
Publicado: (2023)

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus
por: Jung, Jung Hwa, et al.
Publicado: (2015)

A Contemporary Review of Antiplatelet Therapies in Current Clinical Practice
por: Arockiam, Sacchin, et al.
Publicado: (2023)

Editorial: Established and Novel Roles of Platelets in Health and Disease
por: Jurasz, Paul, et al.
Publicado: (2022)

Inhibition of αIIbβ3 Ligand Binding by an αIIb Peptide that Clasps the Hybrid Domain to the βI Domain of β3
por: Lee, Wen Hwa, et al.
Publicado: (2015)

Precision antiplatelet therapy
por: Rocca, Bianca, et al.
Publicado: (2023)

Dual Antiplatelet Therapy in Coronary Artery Disease
por: Sharma, Raghav, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i32kkp3vkooabo3mogh8uq9e6o